Seymour Oxford Food Bank seeks volunteers for Thanksgiving distribution

SEYMOUR - Volunteers needed! We [at Seymour Oxford Food Bank] are hosting DOUBLE the clients for our Thanksgiving drive this year. We are giving out 1,000 meal baskets!

There are two days to sign up: Saturday, 11/22 (2-4 PM) & Monday, 11/24, (12-2 PM.)

We need people to help us load cars with all the food, set up, break down, etc.
Please read the job description carefully and make sure it's a task you are best suited for.

We will be outside the whole time (whatever the weather may be) and on our feet. Weather-appropriate attire will be needed.
We can't wait to see you for these fun days!
Pick your shift and sign up here: https://signup.com/go/qjMzsMU

THANK YOU! 

From the 'Turnback Tuesday' archives: Main Street in Derby

This week's "Turnback Tuesday" photo shows Main Street in Derby during the early 1900s. It's taken across from Hubbell Brothers Shoe Store and just beyond the intersection leading to the Derby-Shelton Bridge and what is now Route 34 to Monroe.

There is an electric trolley in the middle of the street - which helps date the photo - plus some horses and carriages parked on the roadside. A sanitation worker sweeps up the "products of horse combustion."

[First posted on this date in 2015.]

Thanks goes to Derby Public Library staff for sharing interesting local history each week.

Derby Public Library lists upcoming events in November, December

St. Vincent de Paul Thrift Shop in Derby posts daily sales

 

Beacon Falls Congregational Church to present Cookies & Carols

 

Griffin Health in Derby expands advanced prostate cancer treatment

DERBY - Griffin Health, a leader in precision cancer care, recently launched a Pluvicto® (lutetium Lu 177 vipivotide tetraxetan) Theranostics program in its Nuclear Medicine Department, expanding access to a groundbreaking treatment option for patients with advanced prostate cancer.

Developed by Novartis, Pluvicto is a FDA-approved radioligand therapy for the treatment of adult patients with PSMA-positive metastatic castration-resistant prostate cancer (mCRPC) who have previously been treated with androgen receptor pathway inhibition and taxane-based chemotherapy. 

This therapy targets prostate-specific membrane antigen (PSMA)-positive cancer cells, delivering a radioactive payload directly to the tumor, while minimizing damage to surrounding healthy tissue.

“With the launch of the Pluvicto Theranostics program, Griffin Health continues its commitment to bringing cutting-edge, evidence-based cancer care to our community, ensuring our patients have access to the most advanced treatments close to home,” said Griffin Health Vice President of Diagnostic and Cancer Services Christine Cooper, MS, CNMT, RT(N), RSO, FACHE, FAB. “This therapy revolutionizes personalized medicine and provides new hope for patients who have exhausted other treatment options.”

The Griffin Health Pluvicto Theranostics program is designed to expand access to a cutting-edge, targeted radioligand therapy, enhance coordination of care for men with advanced prostate cancer, and improve quality of life and potentially extend survival for eligible patients. It offers a person-centered multidisciplinary care model, including physicians in Nuclear Medicine, Medical Oncology, and Radiation Oncology as well as Nuclear Medicine Technologists, nursing staff, and patient navigation teams to ensure safe, effective, and personalized treatment delivery. 

As part of a continuous care model, Griffin Health offers PSMA PET/CT imaging for patients to confirm their eligibility before beginning therapy.

For more information, visit www.griffinhealth.org/pluvicto.

Griffin is now accepting referrals for its Pluvicto Theranostics program. Referring providers can contact the Nuclear Medicine Department at 203-732-7271 for more information and orders can be faxed to Central Scheduling at 203-732-1559.

This is a press release from Griffin Health.